cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ardelyx Inc
35 own
39 watching
Current Price
$2.93
$0.15
(5.4%)
logo-ardx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
549.08M
52-Week High
52-Week High
3.43
52-Week Low
52-Week Low
0.4902
Average Volume
Average Volume
5.27M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization549.08M
icon52-Week High3.43
icon52-Week Low0.4902
iconAverage Volume5.27M
iconDividend Yield--
iconP/E Ratio--
What does the Ardelyx Inc do?
Ardelyx, Inc. develops and sells therapeutics for the treatment of cardio renal and gastrointestinal diseases in the United States. Its lead product candidate is tenapanor, which is in Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. The company is also developing RDX7675, which is in Phase III clinical trial for the treatment of people with hyperkalemia; and RDX8940 in Phase I clinical trial for the treatment of patients with NASH and other gastrointestinal indications. Its drug candidates in the stages of research and development include RDX013 for the treatment of patients with hyperkalemia; RDX011 for the discovery and development of second-generation NHE3 inhibitors; and RDX023 for the discovery and development of gut-biased FXR agonists for the treatment of GI and inflammatory diseases. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.
Read More
How much money does Ardelyx Inc make?
News & Events about Ardelyx Inc.
PR Newswire
13days ago
Thinking about buying stock in Neurosense Therapeutics, American Airlines, General Electric, Pfizer, or Ardelyx? Thinking about buying stock in Neurosense Therapeutics, American Airlines, General Electric, Pfizer, or Ardelyx? PR Newswire NEW YORK, Jan. 19, 2023 NEW YORK, Jan. 19, 2023 /PRNewswire...
PR Newswire
1month ago
Thinking about buying stock in Mullen Automotive, Hoth Therapeutics, Futu Holdings, Shaw Communications, or Ardelyx? Thinking about buying stock in Mullen Automotive, Hoth Therapeutics, Futu Holdings, Shaw Communications, or Ardelyx? PR Newswire NEW YORK, Dec. 30, 2022 NEW YORK, Dec. 30, 2022...
PR Newswire
1month ago
Thinking about buying stock in Esports Entertainment, Ardelyx, Gaotu Techedu, Hoth Therapeutics, or IQIYI? Thinking about buying stock in Esports Entertainment, Ardelyx, Gaotu Techedu, Hoth Therapeutics, or IQIYI? PR Newswire NEW YORK, Dec. 29, 2022 NEW YORK, Dec. 29, 2022 /PRNewswire...
PR Newswire
1month ago
FDA Grants Appeal for Ardelyx's XPHOZAH (tenapanor) FDA Grants Appeal for Ardelyx's XPHOZAH (tenapanor) PR Newswire WALTHAM, Mass., Dec. 29, 2022 Office of New Drugs directs the Division of Cardiology and Nephrology to work with Ardelyx to develop a label to support the commercialization of...
PR Newswire
1month ago
Thinking about buying stock in Core Scientific, DBV Technologies, Gaotu Techedu, New Oriental Education, or Ardelyx? Thinking about buying stock in Core Scientific, DBV Technologies, Gaotu Techedu, New Oriental Education, or Ardelyx? PR Newswire NEW YORK, Dec. 23, 2022 NEW YORK, Dec. 23, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Ardelyx Inc share price today?
plus_minus_icon
Can Indians buy Ardelyx Inc shares?
plus_minus_icon
How can I buy Ardelyx Inc shares from India?
plus_minus_icon
Can Fractional shares of Ardelyx Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ardelyx Inc stocks?
plus_minus_icon
What is today’s traded volume of Ardelyx Inc?
plus_minus_icon
What is today’s market capitalisation of Ardelyx Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ardelyx Inc?
plus_minus_icon
What percentage is Ardelyx Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ardelyx Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.93
$0.15
(5.4%)
logo-ardx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$9.44
$0.37 (4.08 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$3.01
$0.06 (2.03 %)
Phibro Animal Health Corp
Phibro Animal Health Corp
$15.40
$0.30 (1.99 %)
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc
$39.09
$1.09 (2.87 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
$9.44
$0.37 (4.08 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$3.01
$0.06 (2.03 %)
Phibro Animal Health Corp
Phibro Animal Health Corp
$15.40
$0.30 (1.99 %)
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc
$39.09
$1.09 (2.87 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00